SYSTEMS, DEVICES AND METHODS USING PHASE-AMPLITUDE COUPLING MEASURES IN IMPLANTABLE MEDICAL DEVICES
A sensor of an implantable medical device senses electrical activity of the brain. A data analyzer of the device monitors an electrographic signal corresponding to the electrical activity of the sensed brain signal, and processes the brain signal to obtain a measure of phase-amplitude coupling. For a selected portion of the electrographic signal, the data analyzer detects first features and second features of the electrographic signal. The first features represent oscillations in a low frequency range, while the second features represent oscillations in a frequency range higher than the low frequency range. For example, the low frequency range may correspond to theta frequency and the higher frequency range may correspond to gamma frequency. The data analyzer determines a measure of phase-amplitude coupling between oscillations in the low frequency range and oscillations in the higher frequency range based on occurrences of second features which coincide with first features.
1 . An implantable medical device comprising:
at least one sensor configured to be implanted in or on a brain of a patient, and to sense electrical activity of the brain; and
a processor coupled to the at least one sensor and configured to:
derive a phase-amplitude coupling index based on one or more measures of phase-amplitude coupling computed based on the sensed electrical activity;
evaluate the phase-amplitude coupling index relative to phase-amplitude coupling index criterion to determine if the patient is, or may soon be, in a state of abnormal neural activity; and
deliver a neuromodulation therapy to the patient if the patient is determined to be in a state of abnormal neural activity, wherein the neuromodulation therapy comprises a first stimulation waveform for a first area of the brain and a second stimulation waveform for a second area of the brain.
2 . The implantable medical device of claim 1 , wherein the neuromodulation therapy is configured to one of: a) increase subsequent measures of phase-amplitude coupling within an area of the brain or between two different areas of the brain, or b) decrease subsequent measures of phase-amplitude coupling within an area of the brain or between two different areas of the brain.
3 . The implantable medical device of claim 1 , wherein the processor delivers a neuromodulation therapy to the patient by being further configured to:
stimulate the first area of the brain with the first stimulation waveform, where the first stimulation waveform comprises electrical stimulation pulses delivered at a low frequency within a low frequency range; and
stimulate the second area of the brain with the second stimulation waveform, where the second stimulation waveform comprises bursts of electrical stimulation pulses, wherein the bursts are delivered at the low frequency, and the electrical stimulation pulses within each burst are delivered at a high frequency greater than the low frequency.
4 . The implantable medical device of claim 3 , wherein:
the processor stimulates the first area of the brain with the first stimulation waveform by being further configured to:
applying the sensed electrical activity of the brain to a low frequency range bandpass filter to obtain a low-frequency filtered brain signal, and
delivering the electrical stimulation pulses of the first stimulation waveform to the first area of the brain in synchrony or near-synchrony with fiducial points of the low-frequency filtered brain signal; and
the processor stimulates the second area of the brain with the second stimulation waveform by being further configured to:
applying the sensed electrical activity to a high frequency range bandpass, and
delivering the bursts of the electrical stimulation pulses of the second stimulation waveform to the second area of the brain at a time offset from fiducial points of the low-frequency filtered brain signal.
5 . The implantable medical device of claim 1 , wherein the processor delivers a neuromodulation therapy to the patient by being further configured to:
apply the sensed electrical activity to a low frequency range bandpass filter to obtain a low frequency of a low-frequency filtered brain signal;
apply the sensed electrical activity to a high frequency range bandpass filter to obtain a high frequency of a high-frequency filtered brain signal;
stimulate the first area of the brain with the first stimulation waveform, wherein the first stimulation waveform comprises electrical stimulation pulses delivered at a first frequency within a low frequency range; and
stimulate the second area of the brain with the second stimulation waveform, wherein the second stimulation waveform comprises electrical stimulation pulses delivered at a second frequency different from the first frequency,
wherein each of the first frequency and the second frequency is between a low frequency range that encompasses the low frequency and a high frequency range that encompasses the high frequency.
6 . The implantable medical device of claim 5 , wherein the processor is further configured to simultaneously stimulate the first area of the brain with the first stimulation waveform and the second area of the brain with the second stimulation waveform.
7 . The implantable medical device of claim 1 , wherein the processor delivers a neuromodulation therapy to the patient by being further configured to:
apply the sensed electrical activity to a low frequency range bandpass filter to obtain a low frequency of a low-frequency filtered brain signal;
apply the sensed electrical activity to a high frequency range bandpass filter to obtain a high frequency of a high-frequency filtered brain signal;
stimulate the first area of the brain with the first stimulation waveform, wherein the first stimulation waveform comprises a plurality of bursts of electrical stimulation pulses delivered at a first burst frequency and the electrical stimulation pulses within each of the plurality of bursts are delivered at a first pulse frequency; and
stimulate the second area of the brain with the second stimulation waveform, wherein the second stimulation waveform comprises a plurality of bursts of electrical stimulation pulses delivered at a second burst frequency and the electrical stimulation pulses within each of the plurality of bursts are delivered at a second pulse frequency,
wherein the first burst frequency, the second burst frequency, the first pulse frequency, and the second pulse frequency are each at a frequency between a low frequency range that encompasses the low frequency and a high frequency range that encompasses the high frequency.
8 . A method of neuromodulation therapy comprising:
sensing electrical activity of a brain with at least one sensor configured to be implanted in or on the brain;
deriving a phase-amplitude coupling index based on one or more measures of phase-amplitude coupling computed based on the sensed electrical activity;
evaluating the phase-amplitude coupling index relative to phase-amplitude coupling index criterion to determine if a patient is, or may soon be, in a state of abnormal neural activity; and
delivering a neuromodulation therapy to the patient if the patient is determined to be in a state of abnormal neural activity, wherein the neuromodulation therapy comprises a first stimulation waveform for a first area of the brain and a second stimulation waveform for a second area of the brain.
9 . The method of claim 8 , wherein the neuromodulation therapy is configured to one of: a) increase subsequent measures of phase-amplitude coupling within an area of the brain or between two different areas of the brain, or b) decrease subsequent measures of phase-amplitude coupling within an area of the brain or between two different areas of the brain.
10 . The method of claim 8 , wherein delivering a neuromodulation therapy comprises:
stimulating the first area of the brain with the first stimulation waveform, where the first stimulation waveform comprises electrical stimulation pulses delivered at a low frequency within a low frequency range; and
stimulating the second area of the brain with bursts of electrical stimulation pulses, wherein the bursts are delivered at the low frequency, and the electrical stimulation pulses within each burst are delivered at a high frequency greater than the low frequency.
11 . The method of claim 10 , wherein:
stimulating the first area of the brain with the first stimulation waveform comprises:
applying the sensed electrical activity of the brain to a low frequency range bandpass filter to obtain a low-frequency filtered brain signal, and
delivering the electrical stimulation pulses of the first stimulation waveform to the first area of the brain in synchrony or near-synchrony with fiducial points of the low-frequency filtered brain signal; and
stimulating the second area of the brain with the second stimulation waveform comprises:
applying the sensed electrical activity to a high frequency range bandpass, and
delivering the bursts of the electrical stimulation pulses of the second stimulation waveform to the second area of the brain at a time offset from fiducial points of the low-frequency filtered brain signal.
12 . The method of claim 8 , wherein delivering a neuromodulation therapy comprises:
applying the sensed electrical activity to a low frequency range bandpass filter to obtain a low frequency of a low-frequency filtered brain signal;
applying the sensed electrical activity to a high frequency range bandpass filter to obtain a high frequency of a high-frequency filtered brain signal;
stimulating first area of the brain with the first stimulation waveform, wherein the first stimulation waveform comprises electrical stimulation pulses delivered at a first frequency within a low frequency range; and
stimulating the second area of the brain with the second stimulation waveform, wherein the second stimulation waveform comprises electrical stimulation pulses delivered at a second frequency different from the first frequency,
wherein each of the first frequency and the second frequency is between a low frequency range that encompasses the low frequency and a high frequency range that encompasses the high frequency.
13 . The method of claim 12 , wherein delivering a neuromodulation therapy further comprises simultaneously stimulating the first area of the brain with the first stimulation waveform and the second area of the brain with the second stimulation waveform.
14 . The method of claim 8 , wherein delivering a neuromodulation therapy comprises:
applying the sensed electrical activity to a low frequency range bandpass filter to obtain a low frequency of a low-frequency filtered brain signal;
applying the sensed electrical activity to a high frequency range bandpass filter to obtain a high frequency of a high-frequency filtered brain signal;
stimulating the first area of the brain with the first stimulation waveform, wherein the first stimulation waveform comprises a plurality of bursts of electrical stimulation pulses delivered at a first burst frequency and the electrical stimulation pulses within each of the plurality of bursts are delivered at a first pulse frequency; and
stimulating the second area of the brain with the second stimulation waveform, wherein the second stimulation waveform comprises a plurality of bursts of electrical stimulation pulses delivered at a second burst frequency and the electrical stimulation pulses within each of the plurality of bursts are delivered at a second pulse frequency,
wherein the first burst frequency, the second burst frequency, the first pulse frequency, and the second pulse frequency are each at a frequency between a low frequency range that encompasses the low frequency and a high frequency range that encompasses the high frequency.